Beijing SL Pharmaceutical Co Ltd (002038.SZ) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · China · ISIN CNE000001L31
Beijing SL Pharmaceutical Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 660.42 m CNY | 623.64 m CNY |
| Gross profit | 448.33 m CNY | 387.56 m CNY |
| Operating income | -119.60 m CNY | -2.65 m CNY |
| EBIT | 27.65 m CNY | -2.65 m CNY |
| Net income | -74.07 m CNY | -347.20 m CNY |
| Diluted EPS – continuing operations | -0.07 CNY | -0.34 CNY |
Full history since 2001, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Beijing SL Pharmaceutical Co Ltd
Beijing SL Pharmaceutical Co., Ltd., a biopharmaceutical company, research, development, and production of genetic engineering and related drugs People's Republic of China and internationally. The company's finished formulations include temozolomide; arsenic trioxide; lenalidomide capsules; paclitaxel injection; docetaxel injection; thymopentin; vinorelbine tartrate injection; hydroxyl-camptothecine; nimustine hydrochloride; asparaginase; PEG L-asparaginase; calcium foliate; recombinant human basic fibroblast growth factor; liraglutide; insulin aspart 30; insulin aspart 50; insulin aspart; dispersible; ornidazole; voriconazole; adefovir dipivoxil; levofloxacin hydrochloride; azithromycin; ribavirin; tenofovir disoproxil fumarate; valacylovir hydrochloride; lysozyme; stavudine; tropisetron hydrochloride; granisetron hydrochloride; omeprazole; coenzyme complex; ginkgo biloba extract; simvastatin; telmisartan; naftopidil; nicergoline; zaleplon; cytidine disodium triphosphate; febuxostat; filgrastim; recombinant human interleukin-11; and recombinant human interleukin-2 products. The company was formerly known as Beijing BaiLuyuan Bio-Pharmaceutical Co., Ltd and changed its name to Beijing SL Pharmaceutical Co., Ltd. in 1998. Beijing SL Pharmaceutical Co., Ltd. was founded in 1994 and is headquartered in Beijing, the People's Republic of China.
More stocks
- NAVIENT CORP (NAVI)
- Hiecise Precision Equipment Co Ltd (300809.SZ)
- B-Soft Co Ltd (300451.SZ)
- Zhejiang Jingxing Paper Joint Stock Co Ltd (002067.SZ)
- Allmed Medical Products Co Ltd Class A (002950.SZ)
- Burford Capital Ltd (BUR)
- FBD Holdings PLC (EG7.IR)
- Hubei Chaozhuo Aviation Technology Co. Ltd. A (688237.SS)
- Iress Ltd (IRE.AX)
- HEARTLAND EXPRESS INC (HTLD)
- TMK (5330.KL)
- Unilumin Group Co Ltd (300232.SZ)
Not investment advice. All data without warranty, price as of 06.11.2026. Details in the risk notice.